Global Oncology Biosimilars Sales Market Report 2016

October 2016 | 125 pages | ID: GD0CABA437AEN
S&P Consulting

Abstracts

The global oncology biosimilars market will witness substantial growth over the forecast period and is expected to grow at very impressive CAGR during the forecast period. The increasing need for cost-effective treatment methodologies will aid in the stable growth of this market during the forecast period. The high cost of branded biologic oncological drugs will force patients to shift toward biosimilars as they are highly cost-effective. Since biosimilars cost 10%-30% lesser than their parent counterparts, there is the presence of unmet medical needs for such products. This allows domestic manufacturers to market generic versions of the biologic compounds at a lower price, which in turn results in market growth.

Cancer represents a massive burden on healthcare systems worldwide due to the high cost of treatment therapeutics. The patent expiry of several cancer therapeutics has allowed the entry of biosimilars, which are being incorporated into oncology treatment practices. Biosimilars are synthesized with the use of biologic components such as monoclonal antibodies, proteins, hormones, nucleic acids, colony stimulating factors, interleukins, and enzymes. The market offers huge growth opportunities for vendors because of the growing incidence of cancer. The clinical pipeline for cancer biosimilars is vast, featuring candidates in different stages of development. Around 30% of all the biosimilars that are awaiting the US FDA’s approval are monoclonal antibodies, including biosimilars of Avastin, MabThera, and Herceptin.

Factors like the arrival of new biosimilars to drive market growth during the forecast period. Unlike generic drugs, which have APIs that are identical to original drugs, biosimilars are similar to their originator biologic compounds. Biosimilars developed by different manufacturers differ from the original product as well as from each other. Since they are less expensive than biologics, patients will be able to afford and access biosimilars more easily than biologics. Rise in number of patent expiries, increase in prevalence of cancer, growing aging population, promising drug pipeline, need for cost-effective treatment, favorable government regulations are some of the key drivers promoting the growth of oncology biosimilars market.

The report offers a comprehensive evaluation of the market. It does so via in-depth insights, understanding market evolution by tracking historical developments, and analyzing the present scenario and future projections based on optimistic and likely scenarios. Each research report serves as a repository of analysis and information for every facet of the market, including but not limited to: Regional markets, technology developments, types, applications, and the competitive landscape.

The study is a source of reliable data on:

• Key market segments and sub-segments
• Evolving market trends and dynamics
• Changing supply and demand scenarios
• Quantifying market opportunities through market sizing and market forecasting
• Tracking current trends/opportunities/challenges
• Competitive insights
• Opportunity mapping in terms of technological breakthroughs

This research report analyzes this market on the basis of its market segments, major geographies, and current market trends. Geographies analyzed under this research report include:

• United States
• China
• Europe
• Japan

The Major players reported in the market include:

• Biocon
• Amgen
• Celltrion
• Hospira
• Biogen
• Mylan
• Pfizer
• Dr. Reddy's Laboratories
• Roche
• GlaxoSmithKline (GSK)
• Merck
• Sanofi and Sandoz.

Product Segment Analysis:

• Type I
• Type II
• Type III

Application Segment Analysis:

• Application I
• Application II
• Application III

Reasons for Buying this Report

• This report provides pin-point analysis for changing competitive dynamics
• It provides a forward looking perspective on different factors driving or restraining market growth
• It provides a six-year forecast assessed on the basis of how the market is predicted to grow
• It helps in understanding the key product segments and their future
• It provides pin point analysis of changing competition dynamics and keeps you ahead of competitors
• It helps in making informed business decisions by having complete insights of market and by making in-depth analysis of market segments
• It provides distinctive graphics and exemplified analysis of major market segments

Contents

1 ONCOLOGY BIOSIMILARS MARKET OVERVIEW

1.1 Product Overview and Scope of Oncology Biosimilars
1.2 Classification of Oncology Biosimilars
  1.2.1 Type I
  1.2.2 Type II
  1.2.3 Type III
1.3 Application of Oncology Biosimilars
  1.3.1 Application
  1.3.2 Application
  1.3.3 Application
1.4 Oncology Biosimilars Market States Status and Prospect (2011-2021) by Regions
  1.4.1 United States
  1.4.2 China
  1.4.3 Europe
  1.4.4 Japan
1.5 Global Market Size of Oncology Biosimilars (2011-2021)
  1.5.1 Global Oncology Biosimilars Sales and Growth Rate (2011-2021)
  1.5.2 Global Oncology Biosimilars Revenue and Growth Rate (2011-2021)
2 GLOBAL ECONOMIC IMPACT ON ONCOLOGY BIOSIMILARS INDUSTRY

2.1 Global Macroeconomic Environment Analysis
  2.1.1 Global Macroeconomic Analysis
  2.1.2 Global Macroeconomic Environment Development Trend
2.2 Global Macroeconomic Environment Analysis by Regions
2.3 Effects to Oncology Biosimilars Industry
3 ONCOLOGY BIOSIMILARS MAUFACTURING COST ANALYSIS

3.1 Oncology Biosimilars Key Raw Materials Analysis
  3.1.1 Key Raw Materials
  3.1.2 Price Trend of Key Raw Materials
  3.1.3 Key Suppliers of Raw Materials
  3.1.4 Market Concentration Rate of Raw Materials
3.2 Proportion of Manufacturing Cost Structure
  3.2.1 Raw Materials
  3.2.2 Labor Cost
  3.2.3 Manufacturing Process Analysis of Oncology Biosimilars
4 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

4.1 Oncology Biosimilars Industrial Chain Analysis
4.2 Upstream Raw Materials Sourcing
4.3 Raw Materials Sources of Oncology Biosimilars Major Manufacturers in 2015
4.4 Downstream Buyers
5 GLOBAL ONCOLOGY BIOSIMILARS COMPETITION BY MANUFACTURERS, TYPE AND APPLICATION

5.1 Global Oncology Biosimilars Market Competition by Manufacturers
  5.1.1 Global Oncology Biosimilars Sales and Market Share of Key Manufacturers (2011-2016)
  5.1.2 Global Oncology Biosimilars Revenue and Share by Manufacturers (2011-2016)
5.2 Global Oncology Biosimilars (Volume and Value) by Type
  5.5.1 Global Oncology Biosimilars Sales and Market Share by Type (2011-2016)
  5.5.2 Global Oncology Biosimilars Revenue and Market Share by Type (2011-2016)
5.3 Global Oncology Biosimilars (Volume and Value) by Regions
  5.3.1 Global Oncology Biosimilars Sales and Market Share by Regions (2011-2016)
  5.3.2 Global Oncology Biosimilars Revenue and Market Share by Regions (2011-2016)
5.4 Global Oncology Biosimilars (Volume) by Application
6 UNITED STATES ONCOLOGY BIOSIMILARS (VOLUME, VALUE AND SALES PRICE)

6.1 United States Oncology Biosimilars Sales and Value (2011-2016)
  6.1.1 United States Oncology Biosimilars Sales and Growth Rate (2011-2016)
  6.1.2 United States Oncology Biosimilars Revenue and Growth Rate (2011-2016)
  6.1.3 United States Oncology Biosimilars Sales Price Trend (2011-2016)
6.2 United States Oncology Biosimilars Sales and Market Share by Manufacturers
6.3 United States Oncology Biosimilars Sales and Market Share by Type
6.4 United States Oncology Biosimilars Sales and Market Share by Application
7 CHINA ONCOLOGY BIOSIMILARS (VOLUME, VALUE AND SALES PRICE)

7.1 China Oncology Biosimilars Sales and Value (2011-2016)
  7.1.1 China Oncology Biosimilars Sales and Growth Rate (2011-2016)
  7.1.2 China Oncology Biosimilars Revenue and Growth Rate (2011-2016)
  7.1.3 China Oncology Biosimilars Sales Price Trend (2011-2016)
7.2 China Oncology Biosimilars Sales and Market Share by Manufacturers
7.3 China Oncology Biosimilars Sales and Market Share by Type
7.4 China Oncology Biosimilars Sales and Market Share by Application
8 EUROPE ONCOLOGY BIOSIMILARS (VOLUME, VALUE AND SALES PRICE)

8.1 Europe Oncology Biosimilars Sales and Value (2011-2016)
  8.1.1 Europe Oncology Biosimilars Sales and Growth Rate (2011-2016)
  8.1.2 Europe Oncology Biosimilars Revenue and Growth Rate (2011-2016)
  8.1.3 Europe Oncology Biosimilars Sales Price Trend (2011-2016)
8.2 Europe Oncology Biosimilars Sales and Market Share by Manufacturers
8.3 Europe Oncology Biosimilars Sales and Market Share by Type
8.4 Europe Oncology Biosimilars Sales and Market Share by Application
9 JAPAN ONCOLOGY BIOSIMILARS (VOLUME, VALUE AND SALES PRICE)

9.1 Japan Oncology Biosimilars Sales and Value (2011-2016)
  9.1.1 Japan Oncology Biosimilars Sales and Growth Rate (2011-2016)
  9.1.2 Japan Oncology Biosimilars Revenue and Growth Rate (2011-2016)
  9.1.3 Japan Oncology Biosimilars Sales Price Trend (2011-2016)
9.2 Japan Oncology Biosimilars Sales and Market Share by Manufacturers
9.3 Japan Oncology Biosimilars Sales and Market Share by Type
9.4 Japan Oncology Biosimilars Sales and Market Share by Application
10 GLOBAL ONCOLOGY BIOSIMILARS MANUFACTURERS ANALYSIS

10.1 Biocon
  10.1.1 Company Basic Information, Manufacturing Base and Competitors
  10.1.2 Product Type, Application and Specification
  10.1.3 Sales, Revenue, Price and Gross Margin (2011-2016)
  10.1.4 Business Overview
10.2 Amgen
  10.2.1 Company Basic Information, Manufacturing Base and Competitors
  10.2.2 Product Type, Application and Specification
  10.2.3 Sales, Revenue, Price and Gross Margin (2011-2016)
  10.2.4 Business Overview
10.3 Celltrion
  10.3.1 Company Basic Information, Manufacturing Base and Competitors
  10.3.2 Product Type, Application and Specification
  10.3.3 Sales, Revenue, Price and Gross Margin (2011-2016)
  10.3.4 Business Overview
10.4 Hospira
  10.4.1 Company Basic Information, Manufacturing Base and Competitors
  10.4.2 Product Type, Application and Specification
  10.4.3 Sales, Revenue, Price and Gross Margin (2011-2016)
  10.4.4 Business Overview
10.5 Biogen
  10.5.1 Company Basic Information, Manufacturing Base and Competitors
  10.5.2 Product Type, Application and Specification
  10.5.3 Sales, Revenue, Price and Gross Margin (2011-2016)
  10.5.4 Business Overview
10.6 Mylan
  10.6.1 Company Basic Information, Manufacturing Base and Competitors
  10.6.2 Product Type, Application and Specification
  10.6.3 Sales, Revenue, Price and Gross Margin (2011-2016)
  10.6.4 Business Overview
10.7 Pfizer
  10.7.1 Company Basic Information, Manufacturing Base and Competitors
  10.7.2 Product Type, Application and Specification
  10.7.3 Sales, Revenue, Price and Gross Margin (2011-2016)
  10.7.4 Business Overview
10.8 Dr. Reddy'sLaboratories
  10.8.1 Company Basic Information, Manufacturing Base and Competitors
  10.8.2 Product Type, Application and Specification
  10.8.3 Sales, Revenue, Price and Gross Margin (2011-2016)
  10.8.4 Business Overview
10.9 Roche
  10.9.1 Company Basic Information, Manufacturing Base and Competitors
  10.9.2 Product Type, Application and Specification
  10.9.3 Sales, Revenue, Price and Gross Margin (2011-2016)
  10.9.4 Business Overview
10.10 GlaxoSmithKline(GSK)
  10.10.1 Company Basic Information, Manufacturing Base and Competitors
  10.10.2 Product Type, Application and Specification
  10.10.3 Sales, Revenue, Price and Gross Margin (2011-2016)
  10.10.4 Business Overview
10.11 Merck
10.12 Sanofiand
10.13 Sandoz.
11 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

11.1 Marketing Channel
  11.1.1 Direct Marketing
  11.1.2 Indirect Marketing
  11.1.3 Marketing Channel Development Trend
11.2 Market Positioning
  11.2.1 Pricing Strategy
  11.2.2 Brand Strategy
  11.2.3 Target Client
11.3 Distributors/Traders List
12 MARKET EFFECT FACTORS ANALYSIS

12.1 Technology Progress/Risk
  12.1.1 Substitutes Threat
  12.1.2 Technology Progress in Related Industry
12.2 Consumer Needs/Customer Preference Change
12.3 Economic/Political Environmental Change
13 GLOBAL ONCOLOGY BIOSIMILARS MARKET FORECAST (2016-2021)

13.1 Global Oncology Biosimilars Sales, Revenue Forecast (2016-2021)
13.2 Global Oncology Biosimilars Sales Forecast by Regions (2016-2021)
13.3 Global Oncology Biosimilars Sales Forecast by Type (2016-2021)
13.4 Global Oncology Biosimilars Sales Forecast by Application (2016-2021)
14 APPENDIX

List Of Tables

LIST OF TABLES AND FIGURES

Figure Picture of Oncology Biosimilars
Table Classification of Oncology Biosimilars
Figure Global Sales Market Share of Oncology Biosimilars by Type in 2015
Table Applications of Oncology Biosimilars
Figure Global Sales Market Share of Oncology Biosimilars by Application in 2015
Figure United States Oncology Biosimilars Revenue and Growth Rate (2011-2021)
Figure China Oncology Biosimilars Revenue and Growth Rate (2011-2021)
Figure Europe Oncology Biosimilars Revenue and Growth Rate (2011-2021)
Figure Japan Oncology Biosimilars Revenue and Growth Rate (2011-2021)
Figure Global Oncology Biosimilars Sales and Growth Rate (2011-2021)
Figure Global Oncology Biosimilars Revenue and Growth Rate (2011-2021)
Table Global Oncology Biosimilars Sales of Key Manufacturers (2011-2016)
Table Global Oncology Biosimilars Sales Share by Manufacturers (2011-2016)
Figure 2015 Oncology Biosimilars Sales Share by Manufacturers
Figure 2016 Oncology Biosimilars Sales Share by Manufacturers
Table Global Oncology Biosimilars Revenue by Manufacturers (2011-2016)
Table Global Oncology Biosimilars Revenue Share by Manufacturers (2011-2016)
Table 2015 Global Oncology Biosimilars Revenue Share by Manufacturers
Table 2016 Global Oncology Biosimilars Revenue Share by Manufacturers
Table Global Oncology Biosimilars Sales and Market Share by Type (2011-2016)
Table Global Oncology Biosimilars Sales Share by Type (2011-2016)
Figure Sales Market Share of Oncology Biosimilars by Type (2011-2016)
Figure Global Oncology Biosimilars Sales Growth Rate by Type (2011-2016)
Table Global Oncology Biosimilars Revenue and Market Share by Type (2011-2016)
Table Global Oncology Biosimilars Revenue Share by Type (2011-2016)
Figure Revenue Market Share of Oncology Biosimilars by Type (2011-2016)
Figure Global Oncology Biosimilars Revenue Growth Rate by Type (2011-2016)
Table Global Oncology Biosimilars Sales and Market Share by Regions (2011-2016)
Table Global Oncology Biosimilars Sales Share by Regions (2011-2016)
Figure Sales Market Share of Oncology Biosimilars by Regions (2011-2016)
Figure Global Oncology Biosimilars Sales Growth Rate by Regions (2011-2016)
Table Global Oncology Biosimilars Revenue and Market Share by Regions (2011-2016)
Table Global Oncology Biosimilars Revenue Share by Regions (2011-2016)
Figure Revenue Market Share of Oncology Biosimilars by Regions (2011-2016)
Figure Global Oncology Biosimilars Revenue Growth Rate by Regions (2011-2016)
Table Global Oncology Biosimilars Sales and Market Share by Application (2011-2016)
Table Global Oncology Biosimilars Sales Share by Application (2011-2016)
Figure Sales Market Share of Oncology Biosimilars by Application (2011-2016)
Figure Global Oncology Biosimilars Sales Growth Rate by Application (2011-2016)
Figure United States Oncology Biosimilars Sales and Growth Rate (2011-2016)
Figure United States Oncology Biosimilars Revenue and Growth Rate (2011-2016)
Figure United States Oncology Biosimilars Sales Price Trend (2011-2016)
Table United States Oncology Biosimilars Sales by Manufacturers (2011-2016)
Table United States Oncology Biosimilars Market Share by Manufacturers (2011-2016)
Table United States Oncology Biosimilars Sales by Type (2011-2016)
Table United States Oncology Biosimilars Market Share by Type (2011-2016)
Table United States Oncology Biosimilars Sales by Application (2011-2016)
Table United States Oncology Biosimilars Market Share by Application (2011-2016)
Figure China Oncology Biosimilars Sales and Growth Rate (2011-2016)
Figure China Oncology Biosimilars Revenue and Growth Rate (2011-2016)
Figure China Oncology Biosimilars Sales Price Trend (2011-2016)
Table China Oncology Biosimilars Sales by Manufacturers (2011-2016)
Table China Oncology Biosimilars Market Share by Manufacturers (2011-2016)
Table China Oncology Biosimilars Sales by Type (2011-2016)
Table China Oncology Biosimilars Market Share by Type (2011-2016)
Table China Oncology Biosimilars Sales by Application (2011-2016)
Table China Oncology Biosimilars Market Share by Application (2011-2016)
Figure Europe Oncology Biosimilars Sales and Growth Rate (2011-2016)
Figure Europe Oncology Biosimilars Revenue and Growth Rate (2011-2016)
Figure Europe Oncology Biosimilars Sales Price Trend (2011-2016)
Table Europe Oncology Biosimilars Sales by Manufacturers (2011-2016)
Table Europe Oncology Biosimilars Market Share by Manufacturers (2011-2016)
Table Europe Oncology Biosimilars Sales by Type (2011-2016)
Table Europe Oncology Biosimilars Market Share by Type (2011-2016)
Table Europe Oncology Biosimilars Sales by Application (2011-2016)
Table Europe Oncology Biosimilars Market Share by Application (2011-2016)
Figure Japan Oncology Biosimilars Sales and Growth Rate (2011-2016)
Figure Japan Oncology Biosimilars Revenue and Growth Rate (2011-2016)
Figure Japan Oncology Biosimilars Sales Price Trend (2011-2016)
Table Japan Oncology Biosimilars Sales by Manufacturers (2011-2016)
Table Japan Oncology Biosimilars Market Share by Manufacturers (2011-2016)
Table Japan Oncology Biosimilars Sales by Type (2011-2016)
Table Japan Oncology Biosimilars Market Share by Type (2011-2016)
Table Japan Oncology Biosimilars Sales by Application (2011-2016)
Table Japan Oncology Biosimilars Market Share by Application (2011-2016)
Table Biocon Basic Information List
Table Biocon Oncology Biosimilars Sales, Revenue, Price and Gross Margin (2011-2016)
Figure Biocon Oncology Biosimilars Global Market Share (2011-2016)
Table Amgen Basic Information List
Table Amgen Oncology Biosimilars Sales, Revenue, Price and Gross Margin (2011-2016)
Figure Amgen Oncology Biosimilars Global Market Share (2011-2016)
Table Celltrion Basic Information List
Table Celltrion Oncology Biosimilars Sales, Revenue, Price and Gross Margin (2011-2016)
Figure Celltrion Oncology Biosimilars Global Market Share (2011-2016)
Table Hospira Basic Information List
Table Hospira Oncology Biosimilars Sales, Revenue, Price and Gross Margin (2011-2016)
Figure Hospira Oncology Biosimilars Global Market Share (2011-2016)
Table Biogen Basic Information List
Table Biogen Oncology Biosimilars Sales, Revenue, Price and Gross Margin (2011-2016)
Figure Biogen Oncology Biosimilars Global Market Share (2011-2016)
Table Mylan Basic Information List
Table Mylan Oncology Biosimilars Sales, Revenue, Price and Gross Margin (2011-2016)
Figure Mylan Oncology Biosimilars Global Market Share (2011-2016)
Table Pfizer Basic Information List
Table Pfizer Oncology Biosimilars Sales, Revenue, Price and Gross Margin (2011-2016)
Figure Pfizer Oncology Biosimilars Global Market Share (2011-2016)
Table Dr. Reddy’s Laboratories Basic Information List
Table Dr. Reddy’s Laboratories Oncology Biosimilars Sales, Revenue, Price and Gross Margin (2011-2016)
Figure Dr. Reddy’s Laboratories Oncology Biosimilars Global Market Share (2011-2016)
Table Roche Basic Information List
Table Roche Oncology Biosimilars Sales, Revenue, Price and Gross Margin (2011-2016)
Figure Roche Oncology Biosimilars Global Market Share (2011-2016)
Table GlaxoSmithKline (GSK) Basic Information List
Table GlaxoSmithKline (GSK) Oncology Biosimilars Sales, Revenue, Price and Gross Margin (2011-2016)
Figure GlaxoSmithKline (GSK) Oncology Biosimilars Global Market Share (2011-2016)
Table Merck Basic Information List
Table Merck Oncology Biosimilars Sales, Revenue, Price and Gross Margin (2011-2016)
Figure Merck Oncology Biosimilars Global Market Share (2011-2016)
Table Sanofi Basic Information List
Table Sanofi Oncology Biosimilars Sales, Revenue, Price and Gross Margin (2011-2016)
Figure Sanofi Oncology Biosimilars Global Market Share (2011-2016)
Table Sandoz Basic Information List
Table Sandoz Oncology Biosimilars Sales, Revenue, Price and Gross Margin (2011-2016)
Figure Sandoz Oncology Biosimilars Global Market Share (2011-2016)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Oncology Biosimilars
Figure Manufacturing Process Analysis of Oncology Biosimilars
Figure Oncology Biosimilars Industrial Chain Analysis
Table Raw Materials Sources of Oncology Biosimilars Major Manufacturers in 2015
Table Major Buyers of Oncology Biosimilars
Table Distributors/Traders List
Figure Global Oncology Biosimilars Sales and Growth Rate Forecast (2016-2021)
Figure Global Oncology Biosimilars Revenue and Growth Rate Forecast (2016-2021)
Table Global Oncology Biosimilars Sales Forecast by Regions (2016-2021)
Table Global Oncology Biosimilars Sales Forecast by Type (2016-2021)
Table Global Oncology Biosimilars Sales Forecast by Application (2016-2021)